Covalent-Allosteric Inhibitors: Do We Get the Best of Both Worlds?

Area of Science:

• Medicinal Chemistry
• Drug Discovery
• Biochemistry

Background:

• Covalent-allosteric inhibitors (CAIs) offer advantages over traditional covalent or allosteric drugs.
• CAIs combine increased potency, prolonged effects, and reduced resistance with enhanced specificity and lower toxicity.
• They represent a promising strategy for targeting previously undruggable proteins.

Purpose of the Study:

• To analyze the discovery of known CAIs targeting key protein families.
• To discuss the role of computational methods in rational CAI design.
• To highlight the potential of CAIs in drug discovery.

Main Methods:

• Review of existing literature on CAI discovery.
• Analysis of CAIs targeting protein phosphatases, protein kinases, and GTPases.
• Discussion of computational approaches for CAI design.

Main Results:

• Identified successful CAI strategies across diverse protein families.
• Highlighted challenges in the rational design of CAIs.
• Emphasized the utility of computational tools in overcoming design hurdles.

Conclusions:

• CAIs are a powerful strategy for developing novel therapeutics.
• Rational design of CAIs requires integrated experimental and computational approaches.
• Further development of computational methods will accelerate CAI discovery for challenging targets.